Abstract

Kenvue Inc will release its quarterly results on May 07, 2026 Pre-Market; this preview summarizes consensus revenue, margin, and EPS expectations, revisits last quarter’s performance and segment trends, and distills prevailing institutional views since January 01, 2026.

Market Forecast

For the current quarter, market tracking points to revenue of 3.84 billion US dollars, EPS of 0.26, and EBIT of 0.76 billion US dollars; year over year, these imply growth of 3.82% for revenue, 14.84% for EPS, and 7.59% for EBIT. Margin forecasts are not explicitly guided, but recent run-rate suggests investors are watching stability around last quarter’s gross margin and net margin alongside EPS leverage.

Main business momentum is concentrated in everyday consumables across Self Care, Essential Health, and Skin Health and Beauty, with a focus on execution in core brands and shelf productivity. The most promising segment near term is Self Care with quarterly revenue of 1.59 billion US dollars and an expected resilient demand profile; year-over-year specifics for segments were not disclosed in forecasts.

Last Quarter Review

In the prior quarter, Kenvue Inc reported revenue of 3.78 billion US dollars, a gross profit margin of 56.96%, GAAP net profit attributable to shareholders of 0.33 billion US dollars, a net profit margin of 8.73%, and adjusted EPS of 0.27, with revenue up 3.22% year over year and adjusted EPS up 3.85% year over year.

A key highlight was disciplined cost control and brand mix delivering EBIT of 0.75 billion US dollars, modestly ahead of market tracking. By business, Self Care generated 1.59 billion US dollars, Essential Health 1.15 billion US dollars, and Skin Health and Beauty 1.04 billion US dollars; year-over-year segment growth rates were not specified.

Current Quarter Outlook

Main portfolio: Self Care, Essential Health, and Skin Health and Beauty

The base case assumes low single-digit top-line growth led by Self Care and relatively steady performance in Essential Health, while Skin Health and Beauty normalizes pricing and promotional intensity. Trade inventory and shelf resets across major retailers can drive quarterly noise, but the mix should favor stable cash conversion. Gross margin resilience hinges on procurement savings and mix, offset by selective reinvestment into brand support and merchandising.

The company’s ability to sustain EPS growth ahead of revenue presumes continued overhead discipline and contained input-cost inflation versus the prior-year spike. In categories such as cough/cold, pain relief, and allergy—key to Self Care—unit demand has held at structurally higher levels post-pandemic normalization, supporting volume. Essential Health skews to durable personal care habits with relatively low elasticity, anchoring earnings visibility despite category promotions.

International demand and FX are watch items. A stronger US dollar would modestly pressure reported growth, while emerging markets can contribute incremental units where distribution expands. The guide implies a steady cadence of price/pack architecture to maintain category competitiveness without eroding brand equity.

Most promising business: Self Care

Self Care, at 1.59 billion US dollars last quarter, remains the primary growth engine given category breadth across analgesics, upper respiratory, and digestive health. Seasonal patterns can add volatility quarter to quarter, but underlying consumption for flagship brands tends to outpace private label in higher-trust use cases. The demand backdrop, combined with targeted innovation and improved on-shelf availability, should support mid-single-digit revenue growth against modestly easing comps.

Gross margin within Self Care benefits from higher value mix and scale leverage in manufacturing. Promotional calendars have normalized, enabling more surgical discounts and better ROI on activation spend. The key sensitivities are category illness incidence in the quarter and the cadence of retailer inventory rebalancing; a lighter cough/cold season could cap upside, but diversity within the portfolio typically mitigates single-category swings.

Pricing architecture remains supportive. If input costs stay benign, Self Care margin should hold close to the recent company average, helping to deliver EPS growth ahead of revenue. Execution risks include competitive intensity from store brands and shifts in e-commerce share mix, which the company counters with assortment depth and omni-channel execution.

Stock-price drivers this quarter

Investors are focused on three variables: margin trajectory, organic sales growth quality, and any updates on capital allocation. On margin, sustaining gross margin near last quarter’s 56.96% while growing EBIT by high single digits would reinforce the EPS algorithm; a shortfall would likely pressure the multiple. On the top line, the composition of growth—volume versus price—will matter for assessing durability through the rest of the year.

Capital deployment is another swing factor. Evidence of debt reduction progress and disciplined reinvestment in priority brands can underpin sentiment. Conversely, any indication of rising promotional spend to defend share would raise questions about the revenue/margin tradeoff. Post-print commentary on retailer inventory and category consumption will be parsed for read-throughs to second-quarter seasonality and full-year cadence.

Analyst Opinions

Institutional sentiment skews neutral based on coverage updates in the period since January 01, 2026, with multiple notes reiterating Hold/Neutral views and price targets around the low 20s. Recent commentary from RBC Capital, with analyst Nik Modi maintaining a Hold rating and a 21.00 US dollars price target, typifies the majority stance that near-term risk-reward is balanced given modest growth and steady margins.

The neutral camp argues that while revenue is projected to grow 3.82% and EPS 14.84% year over year this quarter, the upside is capped by category normalization and promotional intensity in select aisles. Bullish arguments—focused on Self Care momentum and operating discipline—are acknowledged but not dominant in current previews. The center of gravity for expectations is therefore execution against the margin and EPS pathway, with attention to any guidance color that could shift annual growth toward mid single digits on sales and teens on EPS.